These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8601735)

  • 1. Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.
    Wagner SN; Ockenfels HM; Wagner C; Soyer HP; Goos M
    J Invest Dermatol; 1996 Feb; 106(2):321-6. PubMed ID: 8601735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of stromelysin-3 in basal cell carcinomas.
    Majmudar G; Nelson BR; Jensen TC; Voorhees JJ; Johnson TM
    Mol Carcinog; 1994 Jan; 9(1):17-23. PubMed ID: 8297480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma.
    Roh MR; Zheng Z; Kim HS; Kwon JE; Jeung HC; Rha SY; Chung KY
    Exp Mol Pathol; 2012 Apr; 92(2):236-42. PubMed ID: 22305927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
    Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
    Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
    Polette M; Clavel C; Birembaut P; De Clerck YA
    Pathol Res Pract; 1993 Nov; 189(9):1052-7. PubMed ID: 8302724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in keratinocyte carcinomas.
    Riihilä P; Nissinen L; Kähäri VM
    Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY; Yao JF; Chen XD
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression.
    Airola K; Ahonen M; Johansson N; Heikkilä P; Kere J; Kähäri VM; Saarialho-Kere UK
    J Histochem Cytochem; 1998 Apr; 46(4):437-47. PubMed ID: 9524189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
    Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study.
    Karameris A; Panagou P; Tsilalis T; Bouros D
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1930-6. PubMed ID: 9412577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.
    Poulsom R; Hanby AM; Pignatelli M; Jeffery RE; Longcroft JM; Rogers L; Stamp GW
    J Clin Pathol; 1993 May; 46(5):429-36. PubMed ID: 8391548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.